Related Experiment Videos
Hepatitis C virus and hepatocellular carcinoma
1Division of Internal Medicine, Angela Maria e Antonio Migliavacca Center for Liver Disease, FIRC-University Unit for Liver Cancer, IRCCS Maggiore Hospital, University of Milan, Italy.
Bailliere'S Best Practice & Research. Clinical Gastroenterology
|February 2, 2000
Summary
Hepatitis C virus (HCV) is a significant risk factor for hepatocellular carcinoma (HCC), particularly in patients with cirrhosis. Early detection and treatment of chronic hepatitis C may reduce the risk of developing liver cancer.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatocellular carcinoma (HCC) development is linked to hepatitis C virus (HCV) infection.
- HCV-related liver cancer incidence is rising, particularly in developed nations.
- Tumors often arise in older patients with cirrhosis and may progress slowly.
Purpose of the Study:
- To explore the etiological link between HCV and HCC.
- To understand the progression and risk factors of HCV-related HCC.
- To identify potential prevention and treatment strategies for HCV-associated liver cancer.
Main Methods:
- Observational studies analyzing patient data with transfusion-associated hepatitis.
- Epidemiological analysis of HCV-related HCC incidence and characteristics.
- Investigation into the molecular mechanisms of HCV oncogenesis.
Main Results:
- HCV is identified as a major risk factor for HCC, often developing after cirrhosis.
- HCV-associated HCC shows increasing incidence, typically in older individuals with cirrhosis.
- Tumor progression involves single nodule growth followed by satellite nodules, with hepatic failure as a common cause of death.
Conclusions:
- HCV contributes to HCC development, potentially through cirrhosis or direct oncogenic interactions.
- Primary prevention via HCV vaccination is unavailable.
- Interferon treatment for chronic hepatitis C may lower HCC risk.